Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
472
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
The MEG business of Elekta has been acquired by York Instruments Ltd
Healthcare

The MEG business of Elekta has been acquired by York Instruments Ltd

We advised Elekta AB on the sale of MEGIN, its MEG business, to York Instruments Ltd. Financial details have not been disclosed.

Learn more
Naturex SA has acquired Swedish Oat Fiber AB
Food & Beverage | Healthcare

Naturex SA has acquired Swedish Oat Fiber AB

Naturex SA, the global leader in specialty plant-based natural ingredients, has acquired Swedish Oat Fiber AB, a specialized manufacturer of oat dietary fibers, oat oils and oat proteins. Financial details have not been disclosed.

Learn more
Xbrane Biosciences AB has aquired Primm Pharma
Healthcare

Xbrane Biosciences AB has aquired Primm Pharma

Xbrane Biosciences AB (Xbrane) has acquired Primm Pharma (Primm) for an undisclosed consideration.

Learn more
“We are delighted to have found the right new owner of Kungshusen that will leverage the company platform to further expand the business in the future. The Oaklins team has given us excellent support throughout the whole transaction with their professionalism and dedication.”

Henrik Svärdskog

CEO and Co-owner, Kungshusen Medicinska AB

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=SE&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Belgian radioisotope producer secures US$104.1 million to expand global production

DEAL FLASH: PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Oaklins’ team in Belgium acted as the sole financial advisor in this transaction.

Learn more

Talk to our local advisors

Adel Koubaa

Managing Partner
Stockholm, Sweden
Oaklins Sweden

Meet our global industry specialists

Antoine Lemaire

Partner
Paris, France
Oaklins France

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Stuart Goodman

Partner
London, United Kingdom
Oaklins Evelyn Partners

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital